» Articles » PMID: 10706686

Induction of T Cell Anergy in the Absence of CTLA-4/B7 Interaction

Overview
Journal J Immunol
Date 2000 Mar 8
PMID 10706686
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Immunologic tolerance in T lymphocytes is maintained through both thymic and peripheral contributions. One peripheral tolerance mechanism is the induction of T cell anergy, a form of nonresponsiveness resulting from incomplete T cell activation, such as stimulation through the TCR in the absence of costimulation. Recent reports have suggested that engagement of the inhibitory receptor CTLA-4 by its B7 ligand is critical for the initiation of anergy. We tested the importance of CTLA-4 in anergy induction in primary T cells with an in vitro anergy system. Using both CTLA-4/B7-blocking agents and CTLA-4-deficient T cells, we found that T cell anergy can be established in the absence of CTLA-4 expression and/or function. Even in the absence of CTLA-4 signal transduction, T cells activated solely through TCR ligation lose the ability to proliferate as a result of autocrine IL-2 production upon subsequent receptor engagement. Thus, CTLA-4 signaling is not required for the development of T cell anergy.

Citing Articles

Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells.

Noyes D, Bag A, Oseni S, Semidey-Hurtado J, Cen L, Sarnaik A J Immunother Cancer. 2022; 10(5).

PMID: 35618289 PMC: 9125763. DOI: 10.1136/jitc-2022-004605.


TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes.

Thaker Y, Schneider H, Rudd C Immunol Lett. 2014; 163(1):113-9.

PMID: 25455592 PMC: 4286576. DOI: 10.1016/j.imlet.2014.10.020.


Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.

Da Silva D, Movius C, Raff A, Brand H, Skeate J, Wong M Virology. 2014; 452-453:279-86.

PMID: 24606705 PMC: 3987942. DOI: 10.1016/j.virol.2014.01.031.


T-cell tolerance in cancer.

Nurieva R, Wang J, Sahoo A Immunotherapy. 2013; 5(5):513-531.

PMID: 23638746 PMC: 5103631. DOI: 10.2217/imt.13.33.


Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.

James E, DeVoti J, Rosenthal D, Hatam L, Steinberg B, Abramson A J Immunol. 2011; 186(11):6633-40.

PMID: 21531896 PMC: 3124771. DOI: 10.4049/jimmunol.1004181.